Anxiety and depression in polycystic ovary syndrome: a comprehensive investigation
Received 6 February 2009; received in revised form 21 August 2009; accepted 11 September 2009. published online 01 February 2010. Corrected Proof
Polycystic ovary syndrome (PCOS) is associated with high levels of depression, which impact quality of life and limit self-efficacy, yet less is known about prevalence of anxiety. This cross-sectional, observational study of community-based women with PCOS comprehensively examined mood and found that anxiety existed at higher levels than depression, anxiety was underdiagnosed, and more women with PCOS who reported infertility were depressed.
aThe Jean Hailes Foundation for Women's Health Research Group, Centre for Women's Health Research, Monash Institute of Medical Research, Clayton, Victoria, Australia
bDiabetes Unit, Southern Health, Victoria, Australia
Reprint requests: Amanda Deeks, Ph.D., Monash Institute of Medical Research, Locked Bag 29, Monash Medical Centre, Clayton Road, Clayton, Victoria, Australia 3168 (FAX: 61-3-9594-7550).
A.A.D. has nothing to disclose. M.E.G.-H. has nothing to disclose. H.J.T. has nothing to disclose.
Supported by a BRIDGES Grant from the Global Diabetes Foundation (project number LT07-121). BRIDGES, a Global Diabetes Foundation project, is supported by an educational grant from Eli Lilly and Company. Supported by the Helen Macpherson Smith Trust and the L. E. W. Carty Charitable Trust (Melbourne, Australia).
ABSTRACT